BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32063487)

  • 1. What is the role of medical therapy in adrenal-dependent Cushing's syndrome?
    Braun LT; Reincke M
    Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101376. PubMed ID: 32063487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole.
    Feelders RA; Hofland LJ; de Herder WW
    Neuroendocrinology; 2010; 92 Suppl 1():111-5. PubMed ID: 20829630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
    Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical Management of Cushing Disease.
    Tritos NA; Biller BMK
    Neurosurg Clin N Am; 2019 Oct; 30(4):499-508. PubMed ID: 31471057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs in the medical treatment of Cushing's syndrome.
    Schteingart DE
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cushing's disease: adrenal steroidogenesis inhibitors.
    Pivonello R; Simeoli C; Di Paola N; Colao A
    Pituitary; 2022 Oct; 25(5):726-732. PubMed ID: 36036308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates in adrenal steroidogenesis inhibitors for Cushing's syndrome - A practical guide.
    Varlamov EV; Han AJ; Fleseriu M
    Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101490. PubMed ID: 33707082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological management of Cushing's syndrome: an update.
    Dang CN; Trainer P
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1339-48. PubMed ID: 18209872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapies.
    Fleseriu M; Castinetti F
    Pituitary; 2016 Dec; 19(6):643-653. PubMed ID: 27600150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
    Engelhardt D; Weber MM
    J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):261-7. PubMed ID: 8043488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical therapy of Cushing's disease: where are we now?
    Alexandraki KI; Grossman AB
    Front Horm Res; 2010; 38():165-173. PubMed ID: 20616508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How best to monitor the specific side effects of medical treatments of Cushing's disease.
    Castinetti F
    Best Pract Res Clin Endocrinol Metab; 2022 Dec; 36(6):101718. PubMed ID: 36435719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological treatment in adrenal Cushing's syndrome.].
    Stigliano A; Cerquetti L; Toscano V
    Recenti Prog Med; 2016 Nov; 107(11):574-581. PubMed ID: 27869874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockers.
    Fleseriu M; Petersenn S
    Pituitary; 2015 Apr; 18(2):245-52. PubMed ID: 25560275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials.
    Pivonello R; Ferrigno R; De Martino MC; Simeoli C; Di Paola N; Pivonello C; Barba L; Negri M; De Angelis C; Colao A
    Front Endocrinol (Lausanne); 2020; 11():648. PubMed ID: 33363514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical therapy in severe hypercortisolism.
    Marques JVO; Boguszewski CL
    Best Pract Res Clin Endocrinol Metab; 2021 Mar; 35(2):101487. PubMed ID: 33518458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in medical therapies for Cushing's syndrome.
    Tritos NA; Biller BM
    Discov Med; 2012 Feb; 13(69):171-9. PubMed ID: 22369976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of pharmacological options for Cushing's disease: what are the state-of-the-art options?
    Martino M; Aboud N; Lucchetti B; Salvio G; Arnaldi G
    Expert Opin Pharmacother; 2023 Apr; 24(5):557-576. PubMed ID: 36927238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cushing's disease: current medical therapies and molecular insights guiding future therapies.
    Lau D; Rutledge C; Aghi MK
    Neurosurg Focus; 2015 Feb; 38(2):E11. PubMed ID: 25639313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classic and recent etiologies of Cushing's syndrome: diagnosis and therapy.
    Beauregard C; Dickstein G; Lacroix A
    Treat Endocrinol; 2002; 1(2):79-94. PubMed ID: 15765624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.